It is with great pleasure that we invite you to attend The 3rd International Virtual Congress on Controversies in Fibromyalgia (Fibromyalgia2021) which will take place 24-25 June 2021.
Even as our understanding regarding the pathogenesis and neuroscience underlying fibromyalgia and chronic pain rapidly expand and proliferate in recent years, heated controversies remain regarding many aspects of fibromyalgia, regarding its place in medicine and society and regarding the best ways to alleviate suffering.
Fibromyalgia2021 follows the success of the inaugural Congress (Vienna 2019) and the virtual Congress (2020) and will again expose and shed constructive light on some of these more central controversies, honoring diversity of opinion as well as attempting to forge understanding and a basis for collaboration down the road.
The Congress will welcome researchers, clinicians, Fibromyalgia specialists, treatment experts, pharmaceutical companies and other industry leaders.
The congress will focus on the following key areas:
- Neuro-biological Underpinnings of Fibromyalgia and Centralized Pain
- Classification, Diagnosis, Epidemiology and the Evolving Concept of Fibromyalgia
- Genetics, Pharmacogenentics, and Epigenetics
- Treatment of Fibromyalgia
- Complex CNS
- “Transparent Pain”: How Society Deals with Fibromyalgia
We look forward to meeting you online at Fibromyalgia2021.
Dr. Jacob Ablin
Tel-Aviv Sourasky Medical Center, Israel
Prof. Piercarlo Sarzi-Puttini
L. Sacco University Hospital, Milan, Italy